| Evaluating relationships between symptom duration and persistence of rheumatoid arthritis: does a window of opportunity exist? Results on the Leiden early arthritis clinic and … JAB van Nies, R Tsonaka, C Gaujoux-Viala, B Fautrel, ... Annals of the rheumatic diseases 74 (5), 806-812, 2015 | 231 | 2015 |
| The logistic transform for bounded outcome scores E Lesaffre, D Rizopoulos, R Tsonaka Biostatistics 8 (1), 72-85, 2007 | 170 | 2007 |
| Fatigue in rheumatoid arthritis; a persistent problem: a large longitudinal study HW van Steenbergen, R Tsonaka, TWJ Huizinga, A Boonen, ... RMD open 1 (1), e000041, 2015 | 93 | 2015 |
| A semi-parametric shared parameter model to handle nonmonotone nonignorable missingness R Tsonaka, G Verbeke, E Lesaffre Biometrics 65 (1), 81-87, 2009 | 92 | 2009 |
| Community deworming alleviates geohelminth-induced immune hyporesponsiveness LJ Wammes, F Hamid, AE Wiria, L May, MMM Kaisar, ... Proceedings of the National Academy of Sciences 113 (44), 12526-12531, 2016 | 80 | 2016 |
| The effect of three-monthly albendazole treatment on malarial parasitemia and allergy: a household-based cluster-randomized, double-blind, placebo-controlled trial AE Wiria, F Hamid, LJ Wammes, MMM Kaisar, L May, MA Prasetyani, ... PloS one 8 (3), e57899, 2013 | 74 | 2013 |
| Genetic variants in IL15 associate with progression of joint destruction in rheumatoid arthritis: a multicohort study R Knevel, A Krabben, E Brouwer, MD Posthumus, AG Wilson, E Lindqvist, ... Annals of the rheumatic diseases 71 (10), 1651-1657, 2012 | 66 | 2012 |
| A genetic variant in the region of MMP-9 is associated with serum levels and progression of joint damage in rheumatoid arthritis DPC De Rooy, A Zhernakova, R Tsonaka, A Willemze, BAS Kurreeman, ... Annals of the rheumatic diseases 73 (6), 1163-1169, 2014 | 60 | 2014 |
| Fixation and clinical outcome of uncemented peri-apatite-coated versus cemented total knee arthroplasty: five-year follow-up of a randomised controlled trial using … KT Van Hamersveld, PJ Marang-Van De Mheen, R Tsonaka, ER Valstar, ... The bone & joint journal 99 (11), 1467-1476, 2017 | 58 | 2017 |
| Progression of aortic root dilatation and aortic valve regurgitation after the arterial switch operation RLF van der Palen, T van der Bom, A Dekker, R Tsonaka, N van Geloven, ... Heart 105 (22), 1732-1740, 2019 | 56 | 2019 |
| Tracking disease progression non‐invasively in Duchenne and Becker muscular dystrophies P Spitali, K Hettne, R Tsonaka, M Charrout, J van den Bergen, Z Koeks, ... Journal of cachexia, sarcopenia and muscle 9 (4), 715-726, 2018 | 56 | 2018 |
| Half-dose photodynamic therapy versus eplerenone in chronic central serous chorioretinopathy (SPECTRA): a randomized controlled trial TJ van Rijssen, EHC van Dijk, R Tsonaka, HMA Feenstra, G Dijkman, ... American journal of ophthalmology 233, 101-110, 2022 | 51 | 2022 |
| Comparison of methodologies for analysing the progression of joint destruction in rheumatoid arthritis R Knevel, R Tsonaka, S Le Cessie, MPM van der Linden, TWJ Huizinga, ... Scandinavian journal of rheumatology 42 (3), 182-189, 2013 | 46 | 2013 |
| Assessing the level of consciousness in children: a plea for the Glasgow Coma Motor subscore P Van de Voorde, M Sabbe, D Rizopoulos, R Tsonaka, A De Jaeger, ... Resuscitation 76 (2), 175-179, 2008 | 44 | 2008 |
| Home monitoring reduced short stay admissions in suspected COVID-19 patients: COVID-box project E Dirikgil, R Roos, GH Groeneveld, C Heringhaus, AV Silven, AHJ Petrus, ... European Respiratory Journal 58 (2), 2021 | 43 | 2021 |
| Relationship between genome and epigenome-challenges and requirements for future research G Almouzni, L Altucci, B Amati, N Ashley, D Baulcombe, N Beaujean, ... BMC genomics 15, 1-7, 2014 | 37 | 2014 |
| Crossover to photodynamic therapy or micropulse laser after failure of primary treatment of chronic central serous chorioretinopathy: the REPLACE trial TJ van Rijssen, EHC van Dijk, P Scholz, MB Breukink, G Dijkman, ... American Journal of Ophthalmology 216, 80-89, 2020 | 34 | 2020 |
| Longitudinal serum biomarker screening identifies malate dehydrogenase 2 as candidate prognostic biomarker for Duchenne muscular dystrophy M Signorelli, B Ayoglu, C Johansson, H Lochmüller, V Straub, F Muntoni, ... Journal of cachexia, sarcopenia and muscle 11 (2), 505-517, 2020 | 34 | 2020 |
| Pitfalls of linear regression for estimating slopes over time and how to avoid them by using linear mixed-effects models CJ Janmaat, M van Diepen, R Tsonaka, KJ Jager, C Zoccali, FW Dekker Nephrology Dialysis Transplantation 34 (4), 561-566, 2019 | 32 | 2019 |
| Exacerbated inflammatory signaling underlies aberrant response to BMP9 in pulmonary arterial hypertension lung endothelial cells R Szulcek, G Sanchez-Duffhues, N Rol, X Pan, R Tsonaka, C Dickhoff, ... Angiogenesis 23, 699-714, 2020 | 27 | 2020 |
